278 related articles for article (PubMed ID: 27726240)
21. Multiparametric Magnetic Resonance Imaging Is Associated with Increased Medicare Spending in Prostate Cancer Active Surveillance.
Macleod LC; Yabes JG; Fam MM; Bandari J; Yu M; Maganty A; Furlan A; Filson CP; Davies BJ; Jacobs BL
Eur Urol Focus; 2020 Mar; 6(2):242-248. PubMed ID: 31031042
[TBL] [Abstract][Full Text] [Related]
22. A multiparametric magnetic resonance imaging-based risk model to determine the risk of significant prostate cancer prior to biopsy.
van Leeuwen PJ; Hayen A; Thompson JE; Moses D; Shnier R; Böhm M; Abuodha M; Haynes AM; Ting F; Barentsz J; Roobol M; Vass J; Rasiah K; Delprado W; Stricker PD
BJU Int; 2017 Dec; 120(6):774-781. PubMed ID: 28207981
[TBL] [Abstract][Full Text] [Related]
23. A review of economic evaluations of diagnostic strategies using imaging in men at risk of prostate cancer.
Willis SR; van der Meulen J; Valerio M; Miners A; Ahmed HU; Emberton M
Curr Opin Urol; 2015 Nov; 25(6):483-9. PubMed ID: 26372036
[TBL] [Abstract][Full Text] [Related]
24. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies.
Pokorny MR; de Rooij M; Duncan E; Schröder FH; Parkinson R; Barentsz JO; Thompson LC
Eur Urol; 2014 Jul; 66(1):22-9. PubMed ID: 24666839
[TBL] [Abstract][Full Text] [Related]
25. Cost-Effectiveness Analysis of a Skin Awareness Intervention for Early Detection of Skin Cancer Targeting Men Older Than 50 Years.
Gordon LG; Brynes J; Baade PD; Neale RE; Whiteman DC; Youl PH; Aitken JF; Janda M
Value Health; 2017 Apr; 20(4):593-601. PubMed ID: 28408001
[TBL] [Abstract][Full Text] [Related]
26. In-parallel comparative evaluation between multiparametric magnetic resonance imaging, prostate cancer antigen 3 and the prostate health index in predicting pathologically confirmed significant prostate cancer in men eligible for active surveillance.
Porpiglia F; Cantiello F; De Luca S; Manfredi M; Veltri A; Russo F; Sottile A; Damiano R
BJU Int; 2016 Oct; 118(4):527-34. PubMed ID: 26350955
[TBL] [Abstract][Full Text] [Related]
27. Cost-effectiveness of MRI targeted biopsy strategies for diagnosing prostate cancer in Singapore.
Cheng LJ; Soon SS; Tan TW; Tan CH; Lim TSK; Tay KJ; Loke WT; Ang B; Chiong E; Ng K
BMC Health Serv Res; 2021 Sep; 21(1):909. PubMed ID: 34479565
[TBL] [Abstract][Full Text] [Related]
28. Multiparametric MRI and MRI/TRUS Fusion Guided Biopsy for the Diagnosis of Prostate Cancer.
Schütz V; Kesch C; Dieffenbacher S; Bonekamp D; Hadaschik BA; Hohenfellner M; Radtke JP
Adv Exp Med Biol; 2018; 1096():87-98. PubMed ID: 30324349
[TBL] [Abstract][Full Text] [Related]
29. Cost-Effectiveness Comparison of Imaging-Guided Prostate Biopsy Techniques: Systematic Transrectal Ultrasound, Direct In-Bore MRI, and Image Fusion.
Venderink W; Govers TM; de Rooij M; Fütterer JJ; Sedelaar JPM
AJR Am J Roentgenol; 2017 May; 208(5):1058-1063. PubMed ID: 28225639
[TBL] [Abstract][Full Text] [Related]
30. Dramatic increase in the utilization of multiparametric magnetic resonance imaging for detection and management of prostate cancer.
Oberlin DT; Casalino DD; Miller FH; Meeks JJ
Abdom Radiol (NY); 2017 Apr; 42(4):1255-1258. PubMed ID: 27858090
[TBL] [Abstract][Full Text] [Related]
31. Latest Evidence on the Role of Multiparametric Magnetic Resonance Imaging in Active Surveillance for Insignificant Prostate Cancer: A Systematic Review.
Cantiello F; Manno S; Russo GI; Cimino S; Privitera S; Morgia G; Cicione A; Damiano R
Anticancer Agents Med Chem; 2018; 18(7):925-930. PubMed ID: 29303080
[TBL] [Abstract][Full Text] [Related]
32. Further reduction of disqualification rates by additional MRI-targeted biopsy with transperineal saturation biopsy compared with standard 12-core systematic biopsies for the selection of prostate cancer patients for active surveillance.
Radtke JP; Kuru TH; Bonekamp D; Freitag MT; Wolf MB; Alt CD; Hatiboglu G; Boxler S; Pahernik S; Roth W; Roethke MC; Schlemmer HP; Hohenfellner M; Hadaschik BA
Prostate Cancer Prostatic Dis; 2016 Sep; 19(3):283-91. PubMed ID: 27184812
[TBL] [Abstract][Full Text] [Related]
33. Multiparametric magnetic resonance imaging predicts the presence of prostate cancer in patients with negative prostate biopsy.
Lista F; Castillo E; Gimbernat H; Rodríguez-Barbero JM; Panizo J; Angulo JC
Actas Urol Esp; 2015 Mar; 39(2):85-91. PubMed ID: 25267460
[TBL] [Abstract][Full Text] [Related]
34. Cost-Effectiveness Analysis and Microsimulation of Serial Multiparametric Magnetic Resonance Imaging in Active Surveillance of Localized Prostate Cancer.
Magnani CJ; Hernandez-Boussard T; Baker LC; Goldhaber-Fiebert JD; Brooks JD
J Urol; 2022 Jul; 208(1):80-89. PubMed ID: 35212570
[TBL] [Abstract][Full Text] [Related]
35. Can 3-Tesla pelvic phased-array multiparametric MRI avoid unnecessary repeat prostate biopsy in patients with PSA < 10 ng/mL?
Pepe P; Garufi A; Priolo G; Pennisi M
Clin Genitourin Cancer; 2015 Feb; 13(1):e27-30. PubMed ID: 25081324
[TBL] [Abstract][Full Text] [Related]
36. Multiparametric magnetic resonance imaging enhances detection of significant tumor in patients on active surveillance for prostate cancer.
Abdi H; Pourmalek F; Zargar H; Walshe T; Harris AC; Chang SD; Eddy C; So AI; Gleave ME; Machan L; Goldenberg SL; Black PC
Urology; 2015 Feb; 85(2):423-8. PubMed ID: 25623709
[TBL] [Abstract][Full Text] [Related]
37. Validating multiparametric MRI for diagnosis and monitoring of prostate cancer in patients for active surveillance.
Sahibzada I; Batura D; Hellawell G
Int Urol Nephrol; 2016 Apr; 48(4):529-33. PubMed ID: 26759330
[TBL] [Abstract][Full Text] [Related]
38. Stratification of the aggressiveness of prostate cancer using pre-biopsy multiparametric MRI (mpMRI).
Dwivedi DK; Kumar R; Bora GS; Thulkar S; Sharma S; Gupta SD; Jagannathan NR
NMR Biomed; 2016 Mar; 29(3):232-8. PubMed ID: 26730884
[TBL] [Abstract][Full Text] [Related]
39. Cost-Effectiveness of Urinary Biomarker Panel in Prostate Cancer Risk Assessment.
Govers TM; Caba L; Resnick MJ
J Urol; 2018 Dec; 200(6):1221-1226. PubMed ID: 30012363
[TBL] [Abstract][Full Text] [Related]
40. Use of multiparametric magnetic resonance imaging in prostate cancer active surveillance.
Glass AS; Dall'Era MA
BJU Int; 2019 Nov; 124(5):730-737. PubMed ID: 30740876
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
